Triple-Combination Fixed-Dose Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Moderate-to-Severe Acne: Efficacy and Safety Results From a Pooled Phase 3 Analysis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 8, n. 1, p. s339, 2024. DOI: 10.25251/skin.8.supp.339. Disponível em: https://skin.dermsquared.com/skin/article/view/2411. Acesso em: 18 apr. 2026.